Nasus Pharma Partners with Aptar to Strengthen Commercialisation of Intranasal Epinephrine
The collaboration aims to advance the clinical development and future commercialisation of NS002, Nasus Pharma’s intranasal powder epinephrine product candidate.
Manufacturing | 13/10/2025 | By Darshana | 109
The facility was already US FDA-registered as a medical device establishment, supporting a portfolio of 510(k)-cleared products across multiple therapeutic categories.
Manufacturing | 11/10/2025 | By Darshana | 130
GKB Ophthalmics Cuts Production at Goa Plant Amid Sluggish Market Demand
GKB Ophthalmics has reduced production to 50 percent at its Tivim Industrial Estate plant in Mapusa, Goa, due to a slowdown in market demand and the complete suspension of export orders from its US subsidiary starting October 2025, following the imposition of heavy tariffs.
Manufacturing | 11/10/2025 | By Dineshwori | 143
KLIFO Expands Manufacturing Capacity with New Authorised Clinical Supply Facility in Copenhagen
KLIFO, a leading integrated drug development and clinical supply services provider with over 30 years of expertise, has received official manufacturing and importation authorisation from the Danish Medicines Agency for its new 65,000 sq ft Abildager facility in Copenhagen.
Manufacturing | 10/10/2025 | By Darshana | 149
Zydus Pharmaceuticals (USA) Inc., a subsidiary of Ahmedabad-based Zydus Lifesciences, has initiated a voluntary recall of 8,784 bottles of its liver infection treatment, Entecavir, from the U.S. market.
Manufacturing | 10/10/2025 | By Darshana | 221
PharmaJet, a commercial-stage global leader in needle-free injection systems, has announced the expansion of its manufacturing portfolio with the development of a suite of proprietary, needle-free self-injector pens.
Manufacturing | 09/10/2025 | By Darshana | 206
Lupin to Invest USD 250 Million in New USA Respiratory Drug Manufacturing Facility in Florida
Lupin has announced plans to invest USD 250 million over the next five years to establish a new state-of-the-art manufacturing facility in Coral Springs, Florida. The facility will focus on producing over 25 essential respiratory medicines, including albuterol inhalers.
Manufacturing | 09/10/2025 | By Darshana | 108
Novo Nordisk Cuts Manufacturing Jobs in USA as Global Restructuring Gains Pace
Novo Nordisk has cut production-line jobs at one of its major manufacturing sites in the USA as part of a broader global restructuring effort.
Manufacturing | 08/10/2025 | By Darshana | 252
Eli Lilly and Company has announced plans to invest more than USD 1 billion over the next several years to expand its contract manufacturing footprint in India, aimed at enhancing global access to its innovative medicines.
Manufacturing | 07/10/2025 | By Darshana | 152
PRIP Scheme to Boost Pharma MedTech R&D: Applications Open Now
The Department of Pharmaceuticals (DoP) has invited applications for the Promotion of Research and Innovation in Pharma MedTech sector (PRIP) scheme.
Manufacturing | 03/10/2025 | By Dineshwori | 431
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy